Novartis AG (NVS)
110.59
+1.24
(+1.13%)
USD |
NYSE |
Nov 04, 13:27
Novartis Price to Book Value: 5.104 for Nov. 4, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 01, 2024 | 5.047 |
| October 31, 2024 | 5.003 |
| October 30, 2024 | 5.073 |
| October 29, 2024 | 5.101 |
| October 28, 2024 | 5.337 |
| October 25, 2024 | 5.252 |
| October 24, 2024 | 5.221 |
| October 23, 2024 | 5.265 |
| October 22, 2024 | 5.276 |
| October 21, 2024 | 5.341 |
| October 18, 2024 | 5.408 |
| October 17, 2024 | 5.377 |
| October 16, 2024 | 5.380 |
| October 15, 2024 | 5.364 |
| October 14, 2024 | 5.368 |
| October 11, 2024 | 5.364 |
| October 10, 2024 | 5.299 |
| October 09, 2024 | 5.337 |
| October 08, 2024 | 5.251 |
| October 07, 2024 | 5.255 |
| October 04, 2024 | 5.259 |
| October 03, 2024 | 5.251 |
| October 02, 2024 | 5.283 |
| October 01, 2024 | 5.287 |
| September 30, 2024 | 5.309 |
| Date | Value |
|---|---|
| September 27, 2024 | 5.609 |
| September 26, 2024 | 5.609 |
| September 25, 2024 | 5.648 |
| September 24, 2024 | 5.648 |
| September 23, 2024 | 5.645 |
| September 20, 2024 | 5.625 |
| September 19, 2024 | 5.626 |
| September 18, 2024 | 5.626 |
| September 17, 2024 | 5.613 |
| September 16, 2024 | 5.674 |
| September 13, 2024 | 5.611 |
| September 12, 2024 | 5.614 |
| September 11, 2024 | 5.592 |
| September 10, 2024 | 5.676 |
| September 09, 2024 | 5.684 |
| September 06, 2024 | 5.659 |
| September 05, 2024 | 5.651 |
| September 04, 2024 | 5.791 |
| September 03, 2024 | 5.749 |
| August 30, 2024 | 5.865 |
| August 29, 2024 | 5.842 |
| August 28, 2024 | 5.821 |
| August 27, 2024 | 5.814 |
| August 26, 2024 | 5.780 |
| August 23, 2024 | 5.752 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
2.449
Minimum
Sep 26 2022
5.865
Maximum
Aug 30 2024
3.717
Average
3.602
Median
May 07 2020
Price to Book Value Benchmarks
| Amgen Inc | 22.67 |
| AstraZeneca PLC | 5.609 |
| Johnson & Johnson | 5.458 |
| Eli Lilly and Co | 53.87 |
| Merck & Co Inc | 5.892 |
Price to Book Value Related Metrics
| PE Ratio | 12.96 |
| PS Ratio | 4.541 |
| PEG Ratio | 0.1002 |
| Price to Free Cash Flow | 18.13 |
| Price | 110.59 |
| Earnings Yield | 7.71% |
| Market Cap | 221.10B |
| PEGY Ratio | 0.0977 |
| Operating PE Ratio | 16.68 |
| Normalized PE Ratio | 19.27 |